☰

Jacqueline Montes, Ph.D. - Publications

Affiliations: 
Biobehavioral Science Teachers College, Columbia University, New York, NY, United States 
Area:
Movement disorders, Motor control & learning
Tree Info Grants Similar researchers PubMed Report error

94 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sadjadi R, Kelly K, Glanzman AM, Montes J, Linsenmayer M, Tellez M, Bartlett A, Heintzman S, Kolb SJ, Arnold WD, El-Sheikh B. Psychometric Evaluation of modified Spinal Muscular Atrophy Functional Rating Scale (SMAFRS) in adult patients using Rasch Analysis. Muscle & Nerve. PMID 36605016 DOI: 10.1002/mus.27785  0.309
2022 Cheng R, Feng J, Goodwin AM, Uher D, Rao AK, McDermott MP, De Vivo DC, Ewing Garber C, Montes J. Perceived Exertion is not a Substitute for Fatiguability in Spinal Muscular Atrophy. Muscle & Nerve. PMID 36484158 DOI: 10.1002/mus.27765  0.53
2021 Ardalan A, Yamane N, Rao AK, Montes J, Goldman S. Analysis of gait synchrony and balance in neurodevelopmental disorders using computer vision techniques. Health Informatics Journal. 27: 14604582211055650. PMID 34989252 DOI: 10.1177/14604582211055650  0.445
2021 Coratti G, Pera MC, Montes J, Pasternak A, Scoto M, Baranello G, Messina S, Dunaway Young S, Glanzman AM, Duong T, de Sanctis R, Mazzone ES, Milev E, Rohwer A, Civitello M, et al. Different trajectories in upper limb and gross motor function in spinal muscular atrophy. Muscle & Nerve. PMID 34327716 DOI: 10.1002/mus.27384  0.378
2021 Fragala-Pinkham M, Pasternak A, McDermott MP, Mirek E, Glanzman AM, Montes J, Dunaway Young S, Salazar R, Quigley J, Riley SO, Chiriboga CA, Finkel RS, Tennekoon G, Martens WB, De Vivo DC, et al. Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy. Journal of Pediatric Rehabilitation Medicine. PMID 34275913 DOI: 10.3233/PRM-190664  0.303
2021 Fragala-Pinkham M, Pasternak A, McDermott MP, Mirek E, Glanzman AM, Montes J, Dunaway Young S, Salazar R, Quigley J, Riley SO, Chiriboga CA, Finkel RS, Tennekoon G, Martens WB, De Vivo DC, et al. Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophy. Journal of Pediatric Rehabilitation Medicine. PMID 34275913 DOI: 10.3233/PRM-190664  0.303
2021 Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Bishop KM, Foster R, Liu Y, Ramirez-Schrempp D, Schneider E, Bennett CF, Wong J, Farwell W. Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study. The Lancet. Child & Adolescent Health. PMID 34089650 DOI: 10.1016/S2352-4642(21)00100-0  0.312
2021 Montes J, Goodwin AM, McDermott MP, Uher D, Hernandez FM, Coutts K, Cocchi J, Hauschildt M, Cornett KM, Rao AK, Monani UR, Ewing Garber C, De Vivo DC. Diminished muscle oxygen uptake and fatigue in spinal muscular atrophy. Annals of Clinical and Translational Neurology. PMID 33788421 DOI: 10.1002/acn3.51353  0.536
2020 Trucco F, Ridout D, Scoto M, Coratti G, Main ML, Lofra RM, Mayhew AG, Montes J, Pane M, Sansone V, Albamonte E, D'Amico A, Bertini E, Messina S, Bruno C, et al. Respiratory trajectories in type 2 and non-ambulant 3 Spinal muscular atrophy in the iSMAC cohort study. Neurology. PMID 33067401 DOI: 10.1212/WNL.0000000000011051  0.354
2020 Coratti G, Messina S, Lucibello S, Pera MC, Montes J, Pasternak A, Stat FB, Escudero JE, Mazzone ES, Mayhew A, Glanzman AM, Young SD, Salazar R, Duong T, Lofra RM, et al. Clinical variability in spinal muscular atrophy type III. Annals of Neurology. PMID 32926458 DOI: 10.1002/Ana.25900  0.434
2020 Rodriguez-Torres R, Fabiano J, Goodwin A, Rao AK, Kinirons S, De Vivo D, Montes J. Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy. Journal of Neuromuscular Diseases. PMID 32925091 DOI: 10.3233/Jnd-200550  0.6
2020 Coratti G, Pera MC, Lucibello S, Montes J, Pasternak A, Mayhew A, Glanzman AM, Young SD, Pane M, Scoto M, Messina S, Goemans N, Osorio AN, Pedemonte M, Sansone V, et al. Age and baseline values predict 12 and 24-month functional changes in type 2 SMA. Neuromuscular Disorders : Nmd. PMID 32900576 DOI: 10.1016/J.Nmd.2020.07.005  0.334
2020 Montes J, Yoon LH. Commentary on "Stander Use in Spinal Muscular Atrophy: Results From a Large Natural History Database". Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 32: 242. PMID 32604368 DOI: 10.1097/Pep.0000000000000722  0.434
2020 Mercuri E, Lucibello S, Perulli M, Coratti G, de Sanctis R, Pera MC, Pane M, Montes J, de Vivo DC, Darras BT, Kolb SJ, Finkel RS. Longitudinal natural history of type I spinal muscular atrophy: a critical review. Orphanet Journal of Rare Diseases. 15: 84. PMID 32248834 DOI: 10.1186/S13023-020-01356-1  0.39
2020 Young SD, Montes J, Salazar R, Glanzman AM, Pasternak A, Mirek E, Martens W, Finkel RS, Darras BT, De Vivo DC. Scoliosis Surgery Significantly Impacts Motor Abilities in Higher-functioning Individuals with Spinal Muscular Atrophy1. Journal of Neuromuscular Diseases. PMID 32083590 DOI: 10.3233/Jnd-190462  0.42
2019 Goodwin AM, Cornett KMD, McKay MJ, Burns J, Ewing Garber C, De Vivo DC, Montes J. Limitations of six-minute Walk Test Reference Values for Spinal Muscular Atrophy. Muscle & Nerve. PMID 31884700 DOI: 10.1002/Mus.26794  0.478
2019 Messina S, Frongia AL, Antonaci L, Pera MC, Coratti G, Pane M, Pasternak A, Civitello M, Montes J, Mayhew A, Finkel R, Muntoni F, Mercuri E. A critical review of patient and parent caregiver oriented tools to assess health-related quality of life, activity of daily living and caregiver burden in spinal muscular atrophy. Neuromuscular Disorders : Nmd. PMID 31791871 DOI: 10.1016/J.Nmd.2019.10.001  0.349
2019 Goldman S, McCullough AK, Young SD, Mueller C, Stahl A, Zoeller A, Abbruzzese LD, Rao AK, Montes J. Quantitative gait assessment in children with 16p11.2 syndrome. Journal of Neurodevelopmental Disorders. 11: 26. PMID 31656164 DOI: 10.1186/s11689-019-9286-9  0.474
2019 Montes J, Dunaway Young S, Mazzone ES, Pasternak A, Glanzman AM, Finkel RS, Darras BT, Muntoni F, Mercuri E, De Vivo DC, Bishop KM, Schneider E, Bennett CF, Foster R, Farwell W, et al. Nusinersen Improves Walking Distance and Reduces Fatigue in Later-Onset SMA. Muscle & Nerve. PMID 31298747 DOI: 10.1002/Mus.26633  0.455
2019 Darras BT, Chiriboga CA, Iannaccone ST, Swoboda KJ, Montes J, Mignon L, Xia S, Bennett CF, Bishop KM, Shefner JM, Green AM, Sun P, Bhan I, Gheuens S, Schneider E, et al. Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies. Neurology. PMID 31019106 DOI: 10.1212/Wnl.0000000000007527  0.439
2019 Bartels B, Montes J, van der Pol WL, de Groot JF. Physical exercise training for type 3 spinal muscular atrophy. The Cochrane Database of Systematic Reviews. 3: CD012120. PMID 30821348 DOI: 10.1002/14651858.Cd012120.Pub2  0.36
2019 Pera MC, Coratti G, Mazzone ES, Montes J, Scoto M, De Sanctis R, Main M, Mayhew A, Muni Lofra R, Dunaway Young S, Glanzman AM, Duong T, Pasternak A, Ramsey D, Darras B, et al. Revised Upper Limb Module for Spinal Muscular Atrophy: 12 month changes. Muscle & Nerve. PMID 30677148 DOI: 10.1002/Mus.26419  0.465
2019 Goodwin AM, Montes J, Ensari I, Hernandez FM, Coutts K, Rao AK, Garber CE. Relationship Between Muscle Deoxygenation And Workload At Peak Exercise In Healthy Adults Using Near-infrared Spectroscopy Medicine & Science in Sports & Exercise. 51: 300. DOI: 10.1249/01.Mss.0000561407.14368.E4  0.489
2019 Kirschner J, Darras B, Farrar M, Mercuri E, Chiriboga C, Kuntz N, Shieh P, Tulinius M, Montes J, Reyna S, Gambino G, Foster R, Bhan I, Wong J, Farwell W. P.352Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): results from the SHINE study Neuromuscular Disorders. 29. DOI: 10.1016/J.Nmd.2019.06.514  0.397
2019 Ramsey D, Scoto M, Mayhew A, Lofra RM, Main M, Milev E, Mazzone E, Montes J, Glanzman A, Pasternak A, Duong T, Civitello M, Coratti G, Straub V, Day J, et al. P.220The revised Hammersmith scale (RHS) for spinal muscular atrophy: longitudinal trajectories in a large international cohort of patients with type 2 and 3 SMA Neuromuscular Disorders. 29. DOI: 10.1016/J.Nmd.2019.06.334  0.441
2019 Kirschner J, Darras BT, Farrar MA, Mercuri E, Chiriboga CA, Kuntz NL, Shieh PB, Tulinius M, Montes J, Reyna SP, Gambino G, Foster R, Bhan I, Wong J, Farwell W. Interim report on the safety and efficacy of longer-term treatment with nusinersen in later-onset spinal muscular atrophy (SMA): Results from the shine study Journal of the Neurological Sciences. 405: 248-249. DOI: 10.1016/J.Jns.2019.10.1272  0.388
2018 Young SD, Montes J, Kramer SS, Podwika B, Rao AK, De Vivo DC. Perceived Fatigue in Spinal Muscular Atrophy: A Pilot Study. Journal of Neuromuscular Diseases. PMID 30562906 DOI: 10.3233/Jnd-180342  0.611
2018 Krosschell KJ, Bosch M, Nelson L, Duong T, Lowes LP, Alfano LN, Benjamin D, Carry TB, Devine G, Kelley C, Gadekan R, Malkus EC, Pasternak A, Provance-Orr S, Roemeiser-Logan L, ... ... Montes J, et al. Motor Function Test Reliability During the NeuroNEXT Spinal Muscular Atrophy Infant Biomarker Study. Journal of Neuromuscular Diseases. PMID 30223401 DOI: 10.3233/Jnd-180327  0.333
2018 Montes J, McDermott MP, Mirek E, Mazzone ES, Main M, Glanzman AM, Duong T, Young SD, Salazar R, Pasternak A, Gee R, De Sanctis R, Coratti G, Forcina N, Fanelli L, et al. Ambulatory function in spinal muscular atrophy: Age-related patterns of progression. Plos One. 13: e0199657. PMID 29944707 DOI: 10.1371/Journal.Pone.0199657  0.329
2018 Salazar R, Montes J, Dunaway Young S, McDermott MP, Martens W, Pasternak A, Quigley J, Mirek E, Glanzman AM, Civitello M, Gee R, Duong T, Mazzone ES, Main M, Mayhew A, et al. Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function. Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 30: 209-215. PMID 29924070 DOI: 10.1097/Pep.0000000000000515  0.452
2018 Glanzman AM, Mazzone ES, Young SD, Gee R, Rose K, Mayhew A, Nelson L, Yun C, Alexander K, Darras BT, Zolkipli-Cunningham Z, Tennekoon G, Day JW, Finkel RS, Mercuri E, ... ... Montes J, et al. Evaluator Training and Reliability for SMA Global Nusinersen Trials1. Journal of Neuromuscular Diseases. 5: 159-166. PMID 29865090 DOI: 10.3233/Jnd-180301  0.328
2018 Mercuri E, Darras BT, Chiriboga CA, Day JW, Campbell C, Connolly AM, Iannaccone ST, Kirschner J, Kuntz NL, Saito K, Shieh PB, Tulinius M, Mazzone ES, Montes J, Bishop KM, et al. Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy. The New England Journal of Medicine. 378: 625-635. PMID 29443664 DOI: 10.1056/Nejmoa1710504  0.366
2017 Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, et al. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscular Disorders : Nmd. PMID 29305137 DOI: 10.1016/J.Nmd.2017.11.004  0.355
2017 Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E, Davis RH, Meyer OH, Simonds AK, Schroth MK, et al. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscular Disorders : Nmd. PMID 29290580 DOI: 10.1016/J.Nmd.2017.11.005  0.358
2017 Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K, Servais L, Tizzano E, Topaloglu H, Tulinius M, Montes J, Glanzman AM, Bishop K, et al. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. The New England Journal of Medicine. 377: 1723-1732. PMID 29091570 DOI: 10.1056/Nejmoa1702752  0.362
2017 Montes J, Young SD, Mazzone E, Main M. Neuromuscular Disorders : Nmd. PMID 28917631 DOI: 10.1016/J.Nmd.2017.07.005  0.373
2017 Bishop KM, Montes J, Finkel RS. Motor Milestone Assessment of Infants with Spinal Muscular Atrophy Using the Hammersmith Infant Neurological Exam - Part 2: Experience from a Nusinersen Clinical Study. Muscle & Nerve. PMID 28556387 DOI: 10.1002/Mus.25705  0.376
2017 Pera MC, Coratti G, Forcina N, Mazzone ES, Scoto M, Montes J, Pasternak A, Mayhew A, Messina S, Sframeli M, Main M, Lofra RM, Duong T, Ramsey D, Dunaway S, et al. Content validity and clinical meaningfulness of the HFMSE in spinal muscular atrophy. Bmc Neurology. 17: 39. PMID 28231823 DOI: 10.1186/S12883-017-0790-9  0.468
2017 Ramsey D, Scoto M, Mayhew A, Main M, Mazzone ES, Montes J, de Sanctis R, Dunaway Young S, Salazar R, Glanzman AM, Pasternak A, Quigley J, Mirek E, Duong T, Gee R, et al. Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool. Plos One. 12: e0172346. PMID 28222119 DOI: 10.1371/Journal.Pone.0172346  0.406
2017 Kirschner J, Mercuri E, Finkel RS, Chiriboga CA, Kuntz N, Darras BT, Shieh PB, Saito K, Vivo DCD, Mazzone ES, Montes J, Yang Q, Zhong ZJ, Gheuens S, Bennett CF, et al. Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study Neuropediatrics. 48. DOI: 10.1055/S-0037-1603574  0.389
2017 Finkel R, Kuntz N, Mercuri E, Muntoni F, Chiriboga CA, Darras B, Topaloglu H, Montes J, Su J, Zhong ZJ, Gheuens S, Bennett CF, Schneider E, Farwell W. Interim Efficacy and Safety Results from the Phase 3 ENDEAR Study of Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA) Neuropediatrics. 48. DOI: 10.1055/S-0037-1602912  0.378
2017 Mercuri E, Finkel R, Kirschner J, Chiriboga C, Kuntz N, Darras B, Shieh P, Saito K, De Vivo D, Mazzone E, Montes J, Yang Q, Zhong Z, Gheuens S, Bennett C, et al. Interim analysis of the phase 3 CHERISH study evaluating nusinersen in patients with later-onset spinal muscular atrophy (SMA): Primary and descriptive secondary endpoints European Journal of Paediatric Neurology. 21: e15. DOI: 10.1016/J.Ejpn.2017.04.1220  0.421
2017 Finkel R, Kuntz N, Mercuri E, Chiriboga C, Darras B, Topaloglu H, Montes J, Su J, Zhong Z, Gheuens S, Bennett C, Schneider E, Farwell W. Efficacy and safety of nusinersen in infants with spinal muscular atrophy (SMA): Final results from the phase 3 ENDEAR study European Journal of Paediatric Neurology. 21: e14-e15. DOI: 10.1016/J.Ejpn.2017.04.1219  0.373
2016 Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Yamashita M, Rigo F, Hung G, Schneider E, Norris DA, Xia S, Bennett CF, Bishop KM. Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet (London, England). PMID 27939059 DOI: 10.1016/S0140-6736(16)31408-8  0.45
2016 Montes J, Zanotto D, Dunaway Young S, Salazar R, De Vivo DC, Agrawal S. Gait Assessment with SoleSound Instrumented Footwear in Spinal Muscular Atrophy. Muscle & Nerve. PMID 27863443 DOI: 10.1002/Mus.25484  0.473
2016 De Sanctis R, Coratti G, Pasternak A, Montes J, Pane M, Mazzone ES, Young SD, Salazar R, Quigley J, Pera MC, Antonaci L, Lapenta L, Glanzman AM, Tiziano D, Muntoni F, et al. Developmental milestones in type I spinal muscular atrophy. Neuromuscular Disorders : Nmd. PMID 27769560 DOI: 10.1016/J.Nmd.2016.10.002  0.315
2016 Mazzone ES, Mayhew A, Montes J, Ramsey D, Fanelli L, Dunaway Young S, Salazar R, De Sanctis R, Pasternak A, Glanzman A, Coratti G, Civitello M, Forcina N, Gee R, Duong T, et al. Revised upper limb module for spinal muscular atrophy: Development of a new module. Muscle & Nerve. PMID 27701745 DOI: 10.1002/Mus.25430  0.473
2016 Blumenschine M, Montes J, Rao AK, Engelstad K, De Vivo DC. Analysis of Gait Disturbance in Glut 1 Deficiency Syndrome. Journal of Child Neurology. PMID 27511993 DOI: 10.1177/0883073816661662  0.543
2016 Pasternak A, Sideridis G, Fragala-Pinkham M, Glanzman AM, Montes J, Dunaway S, Salazar R, Quigley J, Pandya S, O'Riley S, Greenwood J, Chiriboga C, Finkel R, Tennekoon G, Martens WB, et al. Rasch analysis of the pediatric evaluation of disability inventory-computer adaptive test (PEDI-CAT) item bank for children and young adults with spinal muscular atrophy. Muscle & Nerve. PMID 27121348 DOI: 10.1002/Mus.25164  0.381
2016 Young SD, Montes J, Kramer SS, Marra J, Salazar R, Cruz R, Chiriboga CA, Garber CE, De Vivo DC. Six-Minute Walk Test is Reliable and Valid in Spinal Muscular Atrophy. Muscle & Nerve. PMID 27015431 DOI: 10.1002/Mus.25120  0.448
2016 Chiriboga CA, Swoboda KJ, Darras BT, Iannaccone ST, Montes J, De Vivo DC, Norris DA, Bennett CF, Bishop KM. Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy. Neurology. PMID 26865511 DOI: 10.1212/Wnl.0000000000002445  0.45
2016 Ramsey D, Scoto M, Mayhew A, Main M, Mazzone E, Montes J, Dunaway S, Salazar R, Glanzman A, Pasternak A, Duong T, Gee R, Civitello M, Bushby K, Day J, et al. Revised Hammersmith scale for spinal muscular atrophy: Longitudinal changes over six and twelve months in a large international cohort Neuromuscular Disorders. 26. DOI: 10.1016/J.Nmd.2016.06.071  0.409
2016 Dunaway Young S, Montes J, Salazar R, Glanzman A, Pasternak A, Quigley J, Ciurylo E, Riley S, Martens W, Gee R, Duong T, Civitello M, Chiriboga C, Tennekoon G, Day J, et al. Should motor function determine the timing of scoliosis surgery in spinal muscular atrophy? Neuromuscular Disorders. 26: S104. DOI: 10.1016/J.Nmd.2016.06.070  0.411
2016 Bartels B, Montes J, van der Pol WL, de Groot JF. Skeletal muscle training for spinal muscular atrophy type 3 Cochrane Database of Systematic Reviews. 2016. DOI: 10.1002/14651858.Cd012120  0.391
2015 Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, Carr B, Cruz R, Strauss NE, Sproule D, De Vivo DC. Single-Blind, Randomized, Controlled Clinical Trial of Exercise in Ambulatory Spinal Muscular Atrophy: Why are the Results Negative? Journal of Neuromuscular Diseases. 2: 463-470. PMID 27858749 DOI: 10.3233/Jnd-150101  0.376
2015 Mercuri E, Finkel R, Montes J, Mazzone ES, Sormani MP, Main M, Ramsey D, Mayhew A, Glanzman AM, Dunaway S, Salazar R, Pasternak A, Quigley J, Pane M, Pera MC, et al. Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials. Neuromuscular Disorders : Nmd. PMID 26776503 DOI: 10.1016/J.Nmd.2015.10.006  0.32
2015 Mazzone E, Montes J, Main M, Mayhew A, Ramsey D, Glanzman AM, Dunaway S, Salazar R, Pasternak A, Quigley J, Pane M, Pera MC, Scoto M, Messina S, Sframeli M, et al. Old measures and new scores in spinal muscular atrophy patients. Muscle & Nerve. 52: 435-7. PMID 26111847 DOI: 10.1002/Mus.24748  0.443
2015 Montes J, Glanzman AM, Mazzone ES, Martens WB, Dunaway S, Pasternak A, Riley SO, Quigley J, Pandya S, De Vivo DC, Kaufmann P, Chiriboga CA, Finkel RS, Tennekoon GI, Darras BT, et al. SMA functional composite score: A functional measure in spinal muscular atrophy. Muscle & Nerve. PMID 25846132 DOI: 10.1002/Mus.24670  0.433
2015 Sivo S, Mazzone E, Antonaci L, De Sanctis R, Fanelli L, Palermo C, Montes J, Pane M, Mercuri E. Upper limb module in non-ambulant patients with spinal muscular atrophy: 12 month changes. Neuromuscular Disorders : Nmd. 25: 212-5. PMID 25500010 DOI: 10.1016/J.Nmd.2014.11.008  0.44
2015 Alter AS, Engelstad K, Hinton VJ, Montes J, Pearson TS, Akman CI, De Vivo DC. Long-term clinical course of Glut1 deficiency syndrome. Journal of Child Neurology. 30: 160-9. PMID 24789115 DOI: 10.1177/0883073814531822  0.302
2015 Leaffer E, Hinton V, Salazar R, Montes J, Dunaway Young S, Holuba LaMarca N, De Vivo D. Pediatrics-1Spinal Muscular Atrophy Type I: Cases of Normal Cognitive Function Despite having Limited Motor Function and Physical-Environmental Interaction Archives of Clinical Neuropsychology. 30: 481.1-481. DOI: 10.1093/Arclin/Acv046.17  0.389
2015 Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Dunaway S, Pasternak A, Salazar R, Bushby K, Finkel R, Mercuri E, Muntoni F. Revised Hammersmith scale for spinal muscular atrophy Neuromuscular Disorders. 25. DOI: 10.1016/J.Nmd.2015.06.044  0.419
2014 Montes J, Garber CE, Kramer SS, Montgomery MJ, Dunaway S, Kamil-Rosenberg S, Carr B, Strauss NE, Sproule D, De Vivo DC. A Randomized, Controlled Clinical Trial of Exercise in Patients with Spinal Muscular Atrophy: Methods and Baseline Characteristics. Journal of Neuromuscular Diseases. 1: 151-161. PMID 27858768 DOI: 10.3233/Jnd-140004  0.417
2014 Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, Kang PB, Foley AR, Yang ML, Martens WB, Oskoui M, Glanzman AM, Flickinger J, Montes J, Dunaway S, et al. Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology. 83: 810-7. PMID 25080519 DOI: 10.1212/Wnl.0000000000000741  0.448
2014 Dunaway S, Montes J, Garber CE, Carr B, Kramer SS, Kamil-Rosenberg S, Strauss N, Sproule D, De Vivo DC. Performance of the timed "up & go" test in spinal muscular atrophy. Muscle & Nerve. 50: 273-7. PMID 24375426 DOI: 10.1002/Mus.24153  0.407
2014 Montes J, Dunaway S, Garber CE, Chiriboga CA, De Vivo DC, Rao AK. Leg muscle function and fatigue during walking in spinal muscular atrophy type 3. Muscle & Nerve. 50: 34-9. PMID 24122959 DOI: 10.1002/Mus.24081  0.607
2014 Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Bushby K, Finkel R, Mercuri E, Muntoni F. P74 Improving standards of care and translational research in spinal muscular atrophy (SMA) – functional scales Neuromuscular Disorders. 24. DOI: 10.1016/S0960-8966(14)70090-2  0.393
2014 Darras B, Chiriboga C, Swoboda K, Iannaccone S, Montes J, Castro D, Holuba N, Raush N, Visyak N, Dunaway S, Trussell D, Pasternak A, Neilson L, Vivo DD, McGuire D, et al. G.O.18 Neuromuscular Disorders. 24: 920. DOI: 10.1016/J.Nmd.2014.06.417  0.312
2014 Finkel RS, Day J, Chiriboga C, Vasjar J, Cook D, Watson K, Paulose S, McMillian L, Cruz R, Montes J, Vivo DCD, Yamashita M, McGuire D, Alexander K, Norris D, et al. G.O.17 Neuromuscular Disorders. 24: 920. DOI: 10.1016/J.Nmd.2014.06.416  0.363
2014 Mazzone E, Mayhew A, Main M, Montes J, Ramsey D, Scoto M, Pane M, Bushby K, Finkel R, Muntoni F, Mercuri E. T.P.37 Neuromuscular Disorders. 24: 905. DOI: 10.1016/J.Nmd.2014.06.368  0.355
2014 Ramsey D, Scoto M, Mayhew A, Main M, Wilson I, Mazzone E, Montes J, Bushby K, Finkel R, Mercuri E, Muntoni F. T.P.35 Neuromuscular Disorders. 24: 904. DOI: 10.1016/J.Nmd.2014.06.366  0.357
2013 Montes J, Blumenschine M, Dunaway S, Alter AS, Engelstad K, Rao AK, Chiriboga CA, Sproule DM, De Vivo DC. Weakness and fatigue in diverse neuromuscular diseases. Journal of Child Neurology. 28: 1277-83. PMID 23847297 DOI: 10.1177/0883073813493663  0.619
2013 Montes J, McIsaac TL, Dunaway S, Kamil-Rosenberg S, Sproule D, Garber CE, De Vivo DC, Rao AK. Falls and spinal muscular atrophy: exploring cause and prevention. Muscle & Nerve. 47: 118-23. PMID 23042039 DOI: 10.1002/Mus.23656  0.735
2013 Dunaway S, Montes J, O'Hagen J, Sproule DM, Vivo DC, Kaufmann P. Independent mobility after early introduction of a power wheelchair in spinal muscular atrophy. Journal of Child Neurology. 28: 576-82. PMID 22772161 DOI: 10.1177/0883073812449383  0.401
2013 Swoboda K, Chiriboga C, Darras B, Iannaccone S, Montes J, Rausch N, Parad R, Johnson S, Vivo DD, Norris D, Alexander K, Bennet FC, Bishop K. O.9 First-in-human phase I study to assess safety, tolerability and dose for intrathecal injection of ISIS-SMNRx in SMA patients Neuromuscular Disorders. 23: 797-798. DOI: 10.1016/J.Nmd.2013.06.559  0.304
2012 Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, Oskoui M, Constantinescu A, Gooch CL, Foley AR, Yang ML, Tawil R, Chung WK, Martens WB, Montes J, et al. Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology. 79: 1889-97. PMID 23077013 DOI: 10.1212/Wnl.0B013E318271F7E4  0.426
2012 Dunaway S, Montes J, Ryan PA, Montgomery M, Sproule DM, De Vivo DC. Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report. Journal of Child Neurology. 27: 779-85. PMID 22156787 DOI: 10.1177/0883073811425423  0.461
2012 Montes J, McIsaac T, Dunaway S, Kamil-Rosenberg S, Sproule D, Garber C, De Vivo D, Rao A. Falls and Spinal Muscular Atrophy (SMA): Exploring Cause and Prevention (P03.177) Neurology. 78: P03.177-P03.177. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.177  0.742
2011 Glanzman AM, McDermott MP, Montes J, Martens WB, Flickinger J, Riley S, Quigley J, Dunaway S, O'Hagen J, Deng L, Chung WK, Tawil R, Darras BT, Yang M, Sproule D, et al. Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatric Physical Therapy : the Official Publication of the Section On Pediatrics of the American Physical Therapy Association. 23: 322-6. PMID 22090068 DOI: 10.1097/Pep.0B013E3182351F04  0.39
2011 Glanzman AM, O'Hagen JM, McDermott MP, Martens WB, Flickinger J, Riley S, Quigley J, Montes J, Dunaway S, Deng L, Chung WK, Tawil R, Darras BT, De Vivo DC, Kaufmann P, et al. Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. Journal of Child Neurology. 26: 1499-507. PMID 21940700 DOI: 10.1177/0883073811420294  0.41
2011 Sproule DM, Montgomery MJ, Punyanitya M, Shen W, Dashnaw S, Montes J, Dunaway S, Finkel R, Darras B, Vivo DC, Kaufmann P. Thigh muscle volume measured by magnetic resonance imaging is stable over a 6-month interval in spinal muscular atrophy. Journal of Child Neurology. 26: 1252-9. PMID 21572051 DOI: 10.1177/0883073811405053  0.372
2011 Montes J, Dunaway S, Montgomery MJ, Sproule D, Kaufmann P, De Vivo DC, Rao AK. Fatigue leads to gait changes in spinal muscular atrophy. Muscle & Nerve. 43: 485-8. PMID 21404286 DOI: 10.1002/Mus.21917  0.604
2011 Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, et al. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Archives of Neurology. 68: 779-86. PMID 21320981 DOI: 10.1001/Archneurol.2010.373  0.428
2011 Sproule DM, Punyanitya M, Shen W, Dashnaw S, Martens B, Montgomery M, Montes J, Battista V, Finkel R, Darras B, De Vivo DC, Kaufmann P. Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. Journal of Child Neurology. 26: 309-17. PMID 20929908 DOI: 10.1177/0883073810380457  0.359
2010 King W, Kissel JT, Montes J, De Vivo DC, Finkel RS. Six-minute walk test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 75: 1121-2; author reply. PMID 20855858 DOI: 10.1212/WNL.0b013e3181f00304  0.364
2010 Sproule DM, Montes J, Dunaway S, Montgomery M, Battista V, Koenigsberger D, Martens B, Shen W, Punyanitya M, Benton M, Butler H, Caracciolo J, Mercuri E, Finkel R, Darras B, et al. Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscular Disorders : Nmd. 20: 448-52. PMID 20610154 DOI: 10.1016/J.Nmd.2010.05.013  0.33
2010 Sproule DM, Montes J, Dunaway SL, Montgomery M, Battista V, Shen W, Punyanitya M, De Vivo DC, Kaufmann P. Bioelectrical impedance analysis can be a useful screen for excess adiposity in spinal muscular atrophy. Journal of Child Neurology. 25: 1348-54. PMID 20388937 DOI: 10.1177/0883073810365185  0.337
2010 Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK, Darras BT, De Vivo DC, Kaufmann P, Finkel RS, et al. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Neurology. 74: 833-8. PMID 20211907 DOI: 10.1212/Wnl.0B013E3181D3E308  0.461
2010 Dunaway S, Montes J, Montgomery M, Battista V, Koo B, Marra J, De Vivo DC, Hynan LS, Iannaccone ST, Kaufmann P. Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscular Disorders : Nmd. 20: 162-5. PMID 20074950 DOI: 10.1016/J.Nmd.2009.12.002  0.329
2009 Montes J, Gordon AM, Pandya S, De Vivo DC, Kaufmann P. Clinical outcome measures in spinal muscular atrophy. Journal of Child Neurology. 24: 968-78. PMID 19509409 DOI: 10.1177/0883073809332702  0.619
2008 Chen A, Montes J, Mitsumoto H. The role of exercise in amyotrophic lateral sclerosis. Physical Medicine and Rehabilitation Clinics of North America. 19: 545-57, ix-x. PMID 18625415 DOI: 10.1016/J.Pmr.2008.02.003  0.316
2007 Gordon PH, Cheng B, Montes J, Doorish C, Albert SM, Mitsumoto H. Outcome measures for early phase clinical trials. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 270-3. PMID 17852017 DOI: 10.1080/17482960701547958  0.347
2007 Montes J, Cheng B, Diamond B, Doorish C, Mitsumoto H, Gordon PH. The Timed Up and Go test: predicting falls in ALS. Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group On Motor Neuron Diseases. 8: 292-5. PMID 17852012 DOI: 10.1080/17482960701435931  0.332
2007 Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX, Mao X, Hays AP, Floyd AG, Battista V, Montes J, Hayes S, Dashnaw S, Kaufmann P, Gordon PH, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 68: 1402-10. PMID 17452585 DOI: 10.1212/01.Wnl.0000260065.57832.87  0.323
Show low-probability matches.